FDA NDC Directory · JSON-LD · Markdown

NEMLUVIO

NDC 0299-6220 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic namenemolizumab-ilto
Labeler / ManufacturerGalderma Laboratories, L.P.
Marketing categoryBiologic License Application · App BLA761390
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · SUBCUTANEOUS
Active ingredientsNEMOLIZUMAB (30 mg/100mg)
Marketing started20240813
Package count2

External sources

Source: openFDA. Public-domain (CC0).